Putz Thomas, Ramoner Reinhold, Gander Hubert, Rahm Andrea, Bartsch Georg, Bernardo Katussevani, Ramsay Steven, Thurnher Martin
Department of Urology and kompetenzzentrum medizin tirol, Innsbruck Medical University, Innsbruck, Austria.
Cancer Immunol Immunother. 2007 May;56(5):627-40. doi: 10.1007/s00262-006-0220-0. Epub 2006 Sep 1.
Bee venom secretory phospholipase A2 (bv-sPLA2) and phosphatidylinositol-(3,4)-bisphosphate (PtdIns(3,4)P2) act synergistically to induce cell death in tumour cells of various origins with concomitant stimulation of the immune system. Here, we investigated the mechanisms involved in such actions and examined structural requirements of PtdIns-homologues to inhibit tumour cells in combination with bv-sPLA2. Renal cancer cells were treated with bv-sPLA2 alone or in combination with PtdIns-homologues. Inhibitory effects on [(3)H] thymidine incorporation and intracellular signal transduction pathways were tested. Reaction products generated by bv-sPLA2 interaction with PtdIns(3,4)P2 were identified by mass spectrometry. Among the tested PtdIns-homologues those with a phosphate esterified to position 3 of the inositol head group, were most efficient in cooperating with bv-sPLA2 to block tumour cell proliferation. Growth inhibition induced by the combined action of bv-sPLA2 with either PtdIns(3,4)bisphosphate or PtdIns(3,4,5)trisphosphate were synergistic and accompanied by potent cell lysis. In contrast, PtdIns, which lacked the phosphate group at position 3, failed to promote synergistic growth inhibition. The combined administration of PtdIns(3,4)P2 and bv-sPLA2 abrogated signal transduction mediated by extracellular signal regulated kinase 1 and 2 and prevented transduction of survival signals mediated by protein kinase B. Surface expression of the epidermal growth factor (EGF)-receptor was reduced after PtdIns(3,4)P2-bv-sPLA2 administration and associated with a blockade of EGF-induced signalling. In addition, mass spectroscopy revealed that bv-sPLA2 cleaves PtdIns(3,4)P2 to generate lyso-PtdIns(3,4)P2. In conclusion, we suggest that the cytotoxic activity mediated by PtdIns(3,4)P2 and bv-sPLA2 is due to cell death that results from disruption of membrane integrity, abrogation of signal transduction and the generation of cytotoxic lyso-PtdIns(3,4)P2.
蜂毒分泌型磷脂酶A2(bv-sPLA2)和磷脂酰肌醇-(3,4)-二磷酸(PtdIns(3,4)P2)协同作用,可诱导多种来源的肿瘤细胞死亡,并同时刺激免疫系统。在此,我们研究了此类作用所涉及的机制,并检测了PtdIns同源物与bv-sPLA2联合抑制肿瘤细胞的结构要求。将肾癌细胞单独用bv-sPLA2处理或与PtdIns同源物联合处理。测试了对[³H]胸苷掺入和细胞内信号转导途径的抑制作用。通过质谱鉴定bv-sPLA2与PtdIns(3,4)P2相互作用产生的反应产物。在测试的PtdIns同源物中,那些在肌醇头部基团的3位磷酸化的同源物,在与bv-sPLA2协同阻断肿瘤细胞增殖方面最为有效。bv-sPLA2与PtdIns(3,4)二磷酸或PtdIns(3,4,5)三磷酸联合作用诱导的生长抑制具有协同性,并伴有强力的细胞裂解。相比之下,在3位缺乏磷酸基团的PtdIns未能促进协同生长抑制。PtdIns(3,4)P2和bv-sPLA2联合给药消除了细胞外信号调节激酶1和2介导的信号转导,并阻止了蛋白激酶B介导的存活信号转导。给予PtdIns(3,4)P2-bv-sPLA2后,表皮生长因子(EGF)受体的表面表达降低,并与EGF诱导的信号传导受阻有关。此外,质谱分析表明bv-sPLA2裂解PtdIns(3,4)P2生成溶血磷脂酰肌醇-(3,4)-二磷酸(lyso-PtdIns(3,4)P2)。总之,我们认为PtdIns(3,4)P2和bv-sPLA2介导的细胞毒性活性是由于膜完整性破坏、信号转导消除以及细胞毒性溶血磷脂酰肌醇-(3,4)-二磷酸的产生导致的细胞死亡。